Combining basal insulin analogs with glucagon-like peptide-1 mimetics.

Abstract

Basal insulin analogs are recognized as an effective method of achieving and maintaining glycemic control for patients with type 2 diabetes. However, the progressive nature of the disease means that some individuals may require additional ways to maintain their glycemic goals. Intensification in these circumstances has traditionally been achieved by the… (More)
DOI: 10.1089/dia.2010.0250

Topics

  • Presentations referencing similar topics